Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 1,093 $ 981
Restricted cash 1,918 2,175
Accounts and other receivables 390 581
Accounts receivable—related party 3 4
Inventory 279 316
Derivative assets 107 63
Other current assets 106 114
Total current assets 3,896 4,234
Property, plant and equipment, net 27,953 27,245
Operating lease assets, net 542 0
Debt issuance costs, net 58 72
Non-current derivative assets 42 54
Goodwill 77 77
Other non-current assets, net 317 305
Total assets 32,885 31,987
Current liabilities    
Accounts payable 66 58
Accrued liabilities 1,101 1,169
Accrued liabilities—related party 5 0
Current debt 0 239
Deferred revenue 108 139
Current operating lease liabilities 325 0
Derivative liabilities 37 128
Other current liabilities 17 9
Total current liabilities 1,659 1,742
Long-term debt, net 28,726 28,179
Non-current operating lease liabilities 207 0
Non-current finance lease liabilities 58 57
Non-current derivative liabilities 39 22
Other non-current liabilities 58 58
Commitments and contingencies (see Note 16)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Common stock, $0.003 par value, Authorized: 480.0 million shares at March 31, 2019 and December 31, 2018; Issued: 270.4 million shares at March 31, 2019 and 269.8 million shares at December 31, 2018
Outstanding: 257.4 million shares at March 31, 2019 and 257.0 million shares at December 31, 2018 1 1
Treasury stock: 13.0 million shares and 12.8 million shares at March 31, 2019 and December 31, 2018, respectively, at cost (418) (406)
Additional paid-in-capital 4,063 4,035
Accumulated deficit (4,015) (4,156)
Total stockholders’ deficit (369) (526)
Non-controlling interest 2,507 2,455
Total equity 2,138 1,929
Total liabilities and equity $ 32,885 $ 31,987